Canada markets closed

Nanobiotix S.A. (NANO.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
6.37+0.16 (+2.58%)
At close: 05:35PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
30,058
30,058
0
10
50
Operating Expenses
Research Development
38,396
38,396
32,636
30,378
24,330
Selling General and Administrative
21,661
21,661
17,480
19,017
14,271
Total Operating Expenses
56,836
56,836
46,703
52,588
36,478
Operating Income or Loss
-26,778
-26,778
-46,703
-52,578
-36,428
Interest Expense
7,982
7,982
5,837
671
333
Total Other Income/Expenses Net
-6,322
-6,322
2,106
6,238
-1,593
Income Before Tax
-39,580
-39,580
-57,033
-46,998
-33,581
Income Tax Expense
120
120
10
5
9
Income from Continuing Operations
-39,700
-39,700
-57,043
-47,003
-33,590
Net Income
-39,700
-39,700
-57,041
-47,003
-33,590
Net Income available to common shareholders
-39,700
-39,700
-57,041
-47,003
-33,590
Basic EPS
-1.68
-1.08
-1.64
-1.35
-1.38
Diluted EPS
-1.68
-1.08
-1.64
-1.35
-1.38
Basic Average Shares
34,924
36,759
34,852
34,733
24,386
Diluted Average Shares
34,924
36,759
34,852
34,733
24,386